Page last updated: 2024-09-03

sc 51316 and exp3174

sc 51316 has been researched along with exp3174 in 2 studies

Compound Research Comparison

Studies
(sc 51316)
Trials
(sc 51316)
Recent Studies (post-2010)
(sc 51316)
Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010) (exp3174)
9002362943

Protein Interaction Comparison

ProteinTaxonomysc 51316 (IC50)exp3174 (IC50)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0013
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0027
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0036
Type-1 angiotensin II receptorHomo sapiens (human)0.002
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0075
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0075

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, WT; Chang, LL; Chang, RS; Chen, TB; Faust, KA; Flanagan, KL; Greenlee, WJ; Lotti, VJ; MacCoss, M; Strelitz, RA1
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR1

Reviews

1 review(s) available for sc 51316 and exp3174

ArticleYear
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
    Bioorganic & medicinal chemistry, 2010, Dec-15, Volume: 18, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan

2010

Other Studies

1 other study(ies) available for sc 51316 and exp3174

ArticleYear
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones.
    Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

    Topics: Angiotensin II; Animals; Binding Sites; Male; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles

1993